Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05766436
Other study ID # FWA 000017585
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 15, 2023
Est. completion date September 30, 2023

Study information

Verified date March 2023
Source NewGiza University
Contact Nada M Aboelrouse, masters
Phone 00201003371346
Email nadaaboelrouse21@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare between the effect of nebulized dexmedetomidine and the effect of oral dispensable film (ODF) melatonin in controlling perioperative anxiety and post operative emergence agitation and their effect on the overall surgical experience.in pediatric patients undergoing day case surgery.


Description:

All patients will be admitted on the day of the surgery and will be instructed to fast 6 hours before surgery for older patients, as for breast fed patients, they will be instructed for 4 hours for breast feeding and for formula fed patients they will be instructed to fast for 6 hours as recommended by the American society of anesthesiologists. Preoperative assessment will be done before surgery by one of the members of the team who will make sure that the inclusion and exclusion criteria of the patients are considered, and baseline vital signs will be recorded. According to randomization that will be done by envelop concealed allocation , the drug will be administered to the patients by a researcher who will not participate in the evaluation of the patients 30 mins before transfer to the operation room (OR): each group will receive the intervention drug Parents are not allowed to accompany their children to the OR according to the hospital policy. On arrival to the OR department the Parental separation anxiety scale (PSAS) will be calculated on entering the operation room standard monitoring will be commenced including ECG, non-invasive blood pressure and pulse oximetry and baseline measurement will be recorded. Inhalational induction will be then started with sevoflurane and mask acceptance will be calculated according to the mask acceptance scale (MAS) intravenous cannulation will be then established after which each patient will receive 1-2 mg/kg Propofol, 1 µg/kg fentanyl to attenuate the stress of intubation and 0.5mg/kg atracurium after tracheal intubation anesthesia will be maintained with sevoflurane 2-4 MAC During the length of the operation vital data will be recorded at 5 minutes interval. all patients will receive IV paracetamol 15mg/kg and patient would receive 1 µg/kg fentanyl as a rescue dose if vital data increased by >20% of the baseline. after the completion of surgery extubating will be performed after meeting extubation criteria and patient will be discharged to post-anesthesia care unit (PACU) in for the first 15 min after admission to PACU the post anesthesia emergence agitation will be assessed by using Pediatric Anesthesia Emergence Delirium Scale (PAED) during the stay in PACU pain will also be assessed by using FLACC score Discharge from PACU will be done after meeting discharge criteria and the time of discharge will be documented. After discharge pain score will be measured using FLACC score at 15, 30, 60 minutes interval postoperative and the total combustion of postoperative analgesics will be calculated as well as the time of discharge from the hospital


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 30, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 10 Years
Eligibility Inclusion Criteria: - Patients of American Society of Anesthesiologists (ASA) physical status I & II - both genders, - = 2 to 10 years, - scheduled for elective day case surgery under general anesthesia Exclusion Criteria: - parents' refusal for participation in the study - ASA III and VI patients with history of chronic illness - runny nose or upper respiratory tract infection - Emergency surgeries with hemodynamic instability - history of allergic reaction to dexmedetomidine or melatonin - History of prematurity - developmental delay - central nervous system disorder, - mental retardation, - neurological or psychiatric illness that may be associated with anxiety and agitation (cerebral palsy, seizure, separation anxiety disorder, ADHD etc.). - treatment with anticonvulsants and sedatives

Study Design


Intervention

Drug:
Dexmedetomidine
receive placebo ODF and 3 µ/kg nebulized dexmedetomidine (Precedex™ rxlist) prepared in 0.9% normal saline to a final volume of 3ml. Nebulization was performed using a wall nebulizer and wall oxygen source on 4 l/min.
Melatonin
will receive placebo nebulizer and 0.4mg/kg of ODF melatonin (metacyst ™ nerhadou) orally allowing the film to dissolve in the patients Oro mucosal lining
Placebo
placebo ODF and 0.9% normal saline nebulizer

Locations

Country Name City State
Egypt Ain shams university hospital Cairo Abbasia

Sponsors (1)

Lead Sponsor Collaborator
nada moahmed aboelrouse

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary perioperative anxiety perioperative anxiety will be measured by using Parental separation anxiety scale (PSAS) will be calculated according to the following:
Behavior of the child during separation from parents will be Excellent if the Patient unafraid, cooperative, or asleep will be given the score of (1)
Behavior of the child during separation from parents will be Good if the patient is Slightly afraid/crying, quiet with reassurance will be given the score (2)
Behavior of the child during separation from parents will be Fair if the patient is Moderately afraid and crying not quit with reassurance with the score (3)
Behavior of the child during separation from parents will be poor if the patient is Crying, need for restraint with the score (4)
the score of (1) means excellent response , score of (2) means good response , score of (3) means fair response and score of (4) means poor response
during the patient separation from the caregiver just as the child is going to the operating theater
Secondary mask acceptance calculated according to the mask acceptance scale (MAS) as following : if the Child is calm, cooperative, or asleep the score will be (1) if the child is in Moderate fear of the mask Manageable with reassurance the score will be(2) if the child Cries, combative and needs restraining the score will be (3)
score of (1) means excellent response ,score of (2) means fair response and score of (3) means poor response
during the mask introduction to start inhalational induction of anesthesia with sevoflurane before skin incision
Secondary post anesthesia emergence agitation will be assessed by using Pediatric Anesthesia Emergence Delirium Scale (PAED) with score
1= calm , 2= not calm but could be easily consoled , 3= moderately agitated or restless and not easily calmed , 4 = combative , excited , thrashing around
first 15 minutes after admission to post- anesthesia care unit
Secondary pain score using Face, leg, activity, cry and Consolability score With score of 0 meaning no pain and requires no intervention and score of 10 indicating the worst imaginable pain requiring rescue analgesia during hospital stay up to 3 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04807998 - Risk Factors for Pediatric Emergence Agitation and Analysis of Serum or Urine Metabonomics in Children With Agitation
Completed NCT00990769 - The Effect of Depth of Anesthesia as Measured by Bispectral Index (BIS) on Emergence Agitation in Children N/A
Not yet recruiting NCT03596775 - Effect of Dexmedetomidine on Emergence Agitation and Postoperative Behavior Changes in Children Early Phase 1
Active, not recruiting NCT03846284 - Caudal Versus Intravenous Magnesium Sulfate on Emergence Agitation After Sevoflurane In Children. N/A
Completed NCT03062488 - Emergence Agitation and Pain Scores in Pediatrics When Comparing Single-modal vs Multi-modal Analgesia for ENT Surgery Early Phase 1
Completed NCT05601674 - The Effect of Low Flow Anesthesia on Postoperative Emergence Agitation in Rhinoplasty N/A
Completed NCT01737593 - Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia? Phase 4
Not yet recruiting NCT05624424 - Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery Phase 4
Completed NCT04168879 - Sphenopalatine Ganglion Block for Nasal Surery N/A
Not yet recruiting NCT06079710 - Effect of Intraoperative and Awakening Electroencephalogram on Awakening Agitation After General Anesthesia in Children
Recruiting NCT04142840 - Dexmedetomidine and Propofol in the Treatment of Emergence Agitation Early Phase 1
Completed NCT04844333 - Effect of Extubation Under Deep Anesthesia on Emergence Agitation of Nasal Surgery N/A
Recruiting NCT02169843 - Small Doses of Dexmedetomidine for Emergence Agitation Phase 4
Completed NCT04820595 - Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial
Not yet recruiting NCT06312618 - Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation Phase 4
Completed NCT03134547 - A Comparison of Emergence Agitation by Sevoflurane for Intraoperative Sedation Associated With Caudal Block N/A
Completed NCT03807011 - Emergence Agitation in Pediatric Strabismus Surgery N/A
Completed NCT04485273 - Effect of Dexmedetomedine in Subtenon's Block on Emergence Agitation in Pediatric Strabismus Surgery N/A
Completed NCT03179293 - Transition to Propofol After Sevoflurane Anaesthesia to Prevent Emergence Agitation Phase 4
Completed NCT05223010 - Melatonin for Pediatric Emergence Agitation Phase 4